Skip to main content
ZTS
NYSE Life Sciences

Zoetis Q3 Revenue Slips 1% as U.S. Pet Sales Fall 8%, but Raises Full-Year Adjusted EPS Outlook

Tom Rudovsky · Reported by BusinessWire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$88.78
Mkt Cap
$36.86B
52W Low
$68.77
52W High
$132.49
52W Position info
29% above low
Off High info
33% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

ZTS sits 29% above its 52-week low of $68.77 on elevated volume (1.9× avg).

Summary

Zoetis posted Q3 revenue of $2.4 billion, down 1% on both a reported and organic operational basis, with net income down 18% to $591 million and GAAP diluted EPS of $1.44. Adjusted diluted EPS came in at $1.75, up 3% reported but only 1% organically. The weak spot is the U.S.: revenue fell 6% to $1.2 billion as companion animal dropped 8% on macro-driven price sensitivity, dermatology competition and generics, while International grew 4% and livestock rose 7% company-wide. Management narrowed full-year revenue to $9.220-$9.320 billion but raised adjusted EPS guidance to $6.25-$6.35 from $6.15-$6.25, helped by a lower tax rate and trimmed R&D spend. The quarter also carried $89 million of IPR&D impairments tied to PetMedix assets and $43 million of restructuring charges, so the adjusted beat masks real GAAP pressure. Watch the 8:30 a.m. ET call for color on U.S. dermatology erosion and whether the raised EPS guide holds if companion animal stays soft.

At the time of this announcement, ZTS was trading at $88.78 on NYSE in the Life Sciences sector, with a market capitalization of approximately $36.9B. The 52-week trading range was $68.77 to $132.49. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

ZTS - Latest Insights

ZTS
Nov 05, 2026, 1:15 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $83.15
Real-time Price: $80.01 info
Change: -$3.13 (-4%) info
Market Cap: $32.826B info
ZTS
Nov 05, 2026, 11:40 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $83.48
Real-time Price: $80.01 info
Change: -$3.46 (-4%) info
Market Cap: $32.826B info
ZTS
Aug 13, 2026, 3:51 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $75.45
Real-time Price: $80.01 info
Change: +$4.56 (+6%) info
Market Cap: $32.826B info
ZTS
Aug 06, 2026, 2:32 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $77.03
Real-time Price: $80.01 info
Change: +$2.98 (+4%) info
Market Cap: $32.826B info
ZTS
Aug 06, 2026, 2:10 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $76.28
Real-time Price: $80.01 info
Change: +$3.73 (+5%) info
Market Cap: $32.826B info